COVID-19 infection in Crohn's disease under treatment with adalimumab

被引：41
作者：
Tursi, Antonio [1 ]
Angarano, Gioacchino [2 ]
Monno, Laura [2 ]
Saracino, Annalisa [2 ]
Signorile, Fabio [2 ]
Ricciardi, Aurelia [2 ]
Papa, Alfredo [3 ]
机构：
[1] Azienda Sanit Locale Barletta Andria Trani, Gastroenterol Serv, Andria, Puglia, Italy
[2] Univ Bari, Bari Univ Hosp, Div Infect Dis, Bari, Puglia, Italy
[3] Univ Cattolica Sacro Cuore, Fac Med & Surg, Div Internal Med & Gastroenterol, Complesso Integrato Columbus, Rome, Lazio, Italy
来源：
GUT | 2020年 / 69卷 / 07期
关键词：
crohn's disease; immune response;
D O I：
10.1136/gutjnl-2020-321240
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1364 / +
页数：2
相关论文
共 50 条
  • [31] Adalimumab reversed a severe lymphopenia in a patient with Crohn's disease
    Taxonera, Carlos
    Luis Mendoza, Juan
    Ortega, Luis
    Inmaculada Perez, Maria
    Diaz-Rubio, Manuel
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (04) : 488 - 491
  • [32] Severe cholestasis due to adalimumab in a Crohn's disease patient
    Kim, Edward
    Bressler, Brian
    Schaeffer, David F.
    Yoshida, Eric M.
    WORLD JOURNAL OF HEPATOLOGY, 2013, 5 (10) : 592 - 595
  • [33] CERTOLIZUMAB PEGOL IN CROHN'S DISEASE REFRACTORY TO INFLIXIMAB AND ADALIMUMAB
    Jose, Morales Lara Ma
    Penella Monica, Martinez
    Guzman Diana, Lacruz
    Vidal Vanessa, Jorge
    Maneiro Vicente, Santaclara
    Sanchez Senador, Moran
    del Carmen, Mira Sirvent Ma
    ATENCION FARMACEUTICA, 2009, 11 (03): : 178 - 180
  • [34] Vitiligo during Treatment of Crohn's Disease with Adalimumab: Adverse Effect or Co-Occurrence?
    Posada, Celia
    Florez, Angeles
    Batalla, Ana
    Alcazar, Juan Jose
    Carpio, Daniel
    CASE REPORTS IN DERMATOLOGY, 2011, 3 (01): : 28 - 31
  • [35] Fever as the Only First Sign of Crohn's Disease-Difficulties in Diagnosis during the COVID-19 Pandemic
    Kesicka, Aleksandra
    Burandt, Judyta
    Glowczewski, Adam
    Krogulska, Aneta
    CHILDREN-BASEL, 2022, 9 (12):
  • [36] Adalimumab as a cause of kidney injury in patients with Crohn's disease
    Skoczynski, Krzysztof
    Koziej, Jan
    Szymanska, Sylwia
    Obrycki, Lukasz
    Grenda, Ryszard
    Litwin, Mieczyslaw
    PEDIATRIC NEPHROLOGY, 2024, 39 (08) : 2359 - 2361
  • [37] The effects of anti-TNF-α treatment with adalimumab on growth in children with Crohn's disease (CD)
    Malik, S.
    Ahmed, S. F.
    Wilson, M. L.
    Shah, N.
    Loganathan, S.
    Naik, S.
    Bourke, B.
    Thomas, A.
    Akobeng, A. K.
    Fagbemi, A.
    Wilson, D. C.
    Russell, R. K.
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (03) : 337 - 344
  • [38] Severe cholestasis due to adalimumab in a Crohn's disease patient
    Edward Kim
    Brian Bressler
    David F Schaeffer
    Eric M Yoshida
    World Journal of Hepatology, 2013, (10) : 592 - 595
  • [39] Interstitial Lung Disease as an Extraintestinal Manifestation of Crohn?s Disease in the Time of COVID-19: A Rare Case Report and Review of the Literature
    Li, Lin
    Liu, Pengwei
    Niu, Xiaoping
    He, Chiyi
    JOURNAL OF INFLAMMATION RESEARCH, 2022, 15 : 5733 - 5737
  • [40] Deterioration of neuroimmune homeostasis in Alzheimer's Disease patients who survive a COVID-19 infection
    Villareal, Jonathan A. B.
    Bathe, Tim
    Hery, Gabriela P.
    Phillips, Jennifer L.
    Tsering, Wangchen
    Prokop, Stefan
    JOURNAL OF NEUROINFLAMMATION, 2024, 21 (01)
12345